- Amersham Health
- GE Healthcare Life Sciences
- Tyco International Ltd.
- Premier Inc.
- EI DuPont de Nemours & Co. Inc.
- Bristol-Myers Squibb Co.
- Bracco SPA
- Merck KGaA
- Molecular Insight Pharmaceuticals Inc.
- Schering AG
- Pharmacia Corp.
- Epix Pharmaceuticals Inc.
- Duke University
- Princeton University
- OncoGenex Pharmaceuticals Inc.
- Molecular Biosystems Inc.
- Alliance Pharmaceutical Corp.
- Corixa Corp.
- Imaging Research Solutions Ltd.
- Medical Research Council
- Pfizer Inc.
- General Electric Co.
- Amersham and Nycomed merge to form Nycomed Amersham PLC
- Tyco acquires Mallinckrodt for $4.2bn
- Bristol-Myers Squibb buys DuPont Pharma for $7.8bn
- Bracco acquires Squibb Diagnostics from Bristol-Myers
- Amersham buys Pharmacia's stake in Amersham Biosciences
- Schering AG gets Japan rights to Epix Medical's MS-325;ends
- Nycomed Amersham Imaging acquires Magnetic Imaging
- Sonus, Nycomed cross-license contrast agent patents
- Mallinckrodt & Molecular Biosystems to develop contrast agent
- Mallinckrodt, Nycomed Amersham settle IP dispute
- Alliance acquires Molecular Biosystems for $11.55mm
- Amersham sells Corixa's Bexxar in Europe
- Nycomed Amersham Imaging, MRC form JV
- Amersham Health, Pfizer in global research deal
- GE Med Systems, Amersham enter PET agreement
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.